Earnings Call · Q4 FY2024·2025-03-31

Q4 24EPS +71.26%·Rev n/aQ3 24EPS +48.74%·Rev n/aQ2 24EPS -100.00%*·Rev n/aQ1 24EPS +54.90%·Rev n/a⚠ consensus missing

BioCardia, Inc. BCDA

Miranda Peto — Leadership Team Member

Peter Altman — President and Chief Executive Officer

David McClung — Chief Financial Officer

−3.0%1d on move date−1.8% vs SPY3d+6.5%5d−18.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BCDA calls or request research access.

More BCDA calls Browse calls Request research access